NEW YORK (GenomeWeb) — OpGen said today that it has submitted its Acuitas AMR Gene Panel for the detection of antibiotic resistance to the US Food and Drug Administration for 510(k) clearance.
The PCR-based test is designed to detect 47 antibiotic resistance genes in less than three hours from bacterial isolates. It is currently available for research use only.